Wird geladen...

Oncolytic Viruses: Priming Time for Cancer Immunotherapy

New immuno-oncology therapies are improving cancer treatments beyond the former standard of care, as evidenced by the recent and continuing clinical approvals for immunotherapies in a broad range of indications. However, a majority of patients (particularly those with immunologically cold tumors) st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BioDrugs
Hauptverfasser: Russell, Luke, Peng, Kah Whye, Russell, Stephen J., Diaz, Rosa Maria
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer International Publishing 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790338/
https://ncbi.nlm.nih.gov/pubmed/31321623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-019-00367-0
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!